Literature DB >> 10660109

Fas-resistance in ATL cell lines not associated with HTLV-I or FAP-1 production.

Y Yamada1, K Sugahara, K Tsuruda, K Nohda, T Hata, T Maeda, M Honda, M Tawara, T Hayashibara, T Joh, M Tomonaga, Y Miyazaki, S Kamihira.   

Abstract

A preventive role for human T-cell leukemia virus type-I (HTLV-I) and Fas-associated phosphatase-1 (FAP-1) in Fas-mediated apoptosis has been reported in HTLV-I-infected cells. In the present study, we examined whether these molecules increased during the acquisition of Fas-resistance in adult T-cell leukemia (ATL) cell lines. SO4, ST1 and KK1 are Fas-sensitive ATL cell lines, and produce small amounts of HTLV-I in vitro. Although their subclones RSO4 and RST1 are completely Fas-resistant, they produced an equivalent amount of HTLV-I to SO4 and ST1. Moreover, FAP-1 mRNA was not detected in these cell lines irrespective of Fas sensitivity. Thus, Fas resistance in ATL cells was not directly associated with the increased production of HTLV-I or FAP-1.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10660109     DOI: 10.1016/s0304-3835(99)00313-4

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  8 in total

1.  MAGI-1 expression is decreased in several types of human T-cell leukemia cell lines, including adult T-cell leukemia.

Authors:  Takashi Kozakai; Masahiko Takahashi; Masaya Higuchi; Toshifumi Hara; Kousuke Saito; Yuetsu Tanaka; Masayoshi Masuko; Jun Takizawa; Hirohito Sone; Masahiro Fujii
Journal:  Int J Hematol       Date:  2017-10-17       Impact factor: 2.490

Review 2.  PTPN13/PTPL1: an important regulator of tumor aggressiveness.

Authors:  Gilles Freiss; Dany Chalbos
Journal:  Anticancer Agents Med Chem       Date:  2011-01       Impact factor: 2.505

3.  Acute type adult T-cell leukemia cells proliferate in the lymph nodes rather than in peripheral blood.

Authors:  Mariko Mizuguchi; Mitsuyoshi Takatori; Shugo Sakihama; Manami Yoshita-Takahashi; Naoki Imaizumi; Yoshiaki Takahashi; Hiroo Hasegawa; Kennosuke Karube; Takuya Fukushima; Masataka Nakamura; Yuetsu Tanaka
Journal:  Cancer Gene Ther       Date:  2022-04-22       Impact factor: 5.987

Review 4.  T-cell control by human T-cell leukemia/lymphoma virus type 1.

Authors:  Genoveffa Franchini; Risaku Fukumoto; Jake R Fullen
Journal:  Int J Hematol       Date:  2003-11       Impact factor: 2.490

5.  Rapid isolation of viral integration site reveals frequent integration of HTLV-1 into expressed loci.

Authors:  Tatsuhiko Ozawa; Takahiro Itoyama; Naoki Sadamori; Yasuaki Yamada; Tomoko Hata; Masao Tomonaga; Masaharu Isobe
Journal:  J Hum Genet       Date:  2004-02-26       Impact factor: 3.172

6.  Xenotransplantation elicits salient tumorigenicity of adult T-cell leukemia-derived cells via aberrant AKT activation.

Authors:  Kazunori Yamaguchi; Tomoka Takanashi; Kentaro Nasu; Keiichi Tamai; Mai Mochizuki; Ikuro Satoh; Shoji Ine; Osamu Sasaki; Kennichi Satoh; Nobuyuki Tanaka; Hideo Harigae; Kazuo Sugamura
Journal:  Cancer Sci       Date:  2016-04-07       Impact factor: 6.716

7.  Crucial role of carbonic anhydrase IX in tumorigenicity of xenotransplanted adult T-cell leukemia-derived cells.

Authors:  Kentaro Nasu; Kazunori Yamaguchi; Tomoka Takanashi; Keiichi Tamai; Ikuro Sato; Shoji Ine; Osamu Sasaki; Kennichi Satoh; Nobuyuki Tanaka; Yuetsu Tanaka; Takuya Fukushima; Hideo Harigae; Kazuo Sugamura
Journal:  Cancer Sci       Date:  2017-03       Impact factor: 6.716

8.  WRN-targeted therapy using inhibitors NSC 19630 and NSC 617145 induce apoptosis in HTLV-1-transformed adult T-cell leukemia cells.

Authors:  R Moles; X T Bai; H Chaib-Mezrag; C Nicot
Journal:  J Hematol Oncol       Date:  2016-11-09       Impact factor: 17.388

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.